Neurology

  • Diabetes & Endocrinology
Semaglutide Drugs Might Help Lower Diabetic Alzheimer's Risk
  • BlackDoctor Pro Editors
  • 10/31/2024

Semaglutide Drugs Might Help Lower Diabetic Alzheimer’s Risk

Semaglutide may lower Alzheimer's risk in diabetics, suggesting neuroprotective benefits. Explore potential shifts in dementia management.
  • Neurology
Air Pollution Tied to Parkinson's Disease Risk
  • BlackDoctor Pro Editors
  • 09/23/2024

Air Pollution Tied to Parkinson’s Disease Risk

Air pollution elevates Parkinson's disease risk, especially in urban cores. Implications for Black communities? Read the full analysis.
  • Neurology
Multiple Sclerosis May Help Shield Against Alzheimer's
  • BlackDoctor Pro Editors
  • 08/27/2024

Multiple Sclerosis May Help Shield Against Alzheimer’s

MS may reduce Alzheimer's risk; understanding this could inform new therapies. Disparities highlight urgent care access improvements. Explore full study implications.
  • Neurology
This Alzheimer's Drug May Also Slow Lewy Body Dementia
  • BlackDoctor Pro Editors
  • 08/26/2024

This Alzheimer’s Drug May Also Slow Lewy Body Dementia

Cholinesterase inhibitors slow Lewy body dementia progression, suggesting updated treatment guidelines. Explore implications for your practice and patients.
  • Neurology
How the Shingles Vaccine Could Impact Dementia
  • BlackDoctor Pro Editors
  • 07/26/2024

How the Shingles Vaccine Could Impact Dementia

Shingrix vaccine may reduce dementia risk by 17%. Impacts Alzheimer's prevention strategies. Explore full study for clinical insights.
  • Neurology
Huntington's Disease Diagnosis Usually Later in Blacks Than Whites
  • BlackDoctor Pro Editors
  • 07/12/2024

Huntington’s Disease Diagnosis Usually Later in Blacks Than Whites

Black patients with Huntington's are diagnosed one year later than whites, impacting care quality and clinical trial eligibility.
  • Neurology
FDA Advisors Support New Alzheimer's Drug from Eli Lilly
  • BlackDoctor Pro Editors
  • 06/11/2024

FDA Advisors Support New Alzheimer’s Drug from Eli Lilly

FDA panel endorses Eli Lilly’s donanemab for early Alzheimer’s, despite risks. Racial disparities noted. Explore full implications.
  • Neurology
7 Conditions That Can Be Mistaken for Trigeminal Neuralgia
  • Audra Neale
  • 05/21/2024

Trigeminal Neuralgia: 7 Conditions That Can Be Mistaken for It

Differentiate trigeminal neuralgia from dental, sinus, TMJ disorders, and more. Accurate diagnosis ensures effective pain management for Black patients. Explore diagnostic strategies.
  • Neurology
How Polluted Areas Contribute to Alzheimer's in Black Adults, radon exposure
  • Shelby Smith
  • 05/20/2024

How Polluted Areas Contribute to Alzheimer’s in Black Adults

Polluted areas may increase Alzheimer's risk in Black adults. Address environmental injustice to protect cognitive health. Read more for action steps.
  • Neurology
AAN Annual Meeting 2024: The Latest Neurological Discoveries
  • BlackDoctor Pro Editors
  • 04/25/2024

AAN Annual Meeting 2024: The Latest Neurological Discoveries

Essential tremor triples dementia risk; disparities limit thrombolytic therapy access. Explore full insights to inform practice enhancements.
  • Cardiology
Good Heart Health May Protect Against Cognitive Decline in Black Women
  • BlackDoctor Pro Editors
  • 04/24/2024

Good Heart Health May Protect Against Cognitive Decline in Black Women

Black women with good heart health may experience less cognitive decline. Early detection and intervention can address racial health disparities. Read the full analysis to understand the implications for cognitive health management in your practice.
  • Neurology
This Neurological Factor Is Keeping Black Patients From Alzheimer's Clinical Trials
  • BlackDoctor Pro Editors
  • 04/19/2024

This Neurological Factor Is Keeping Black Patients From Alzheimer’s Clinical Trials

Black and Hispanic patients face Alzheimer's trial barriers due to differing amyloid levels, highlighting need for diverse research approaches. Explore implications for clinical trial design.
AI-Powered Search. Human-Created Content.

What is the most crucial step to reduce Black maternal mortality rates?

Based on: https://blackdoctor.pro/maternal-mortality-covid-black-women-disparities/

What is the most crucial step to reduce Black maternal mortality rates?

Expert Medical Insights, Straight to Your Inbox

Insights That Keep Black Healthcare Leaders at the Forefront

By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.

Empowering Culturally-Sensitive Healthcare Professionals

BlackDoctor Pro is an online destination created specifically for Black doctors and culturally-sensitive healthcare professionals. Our platform delivers trusted, relevant, and timely medical content, including in-depth articles, the latest treatment updates, healthcare policy, and emerging clinical studies. We are committed to empowering HCPs with the knowledge, resources, and support needed to achieve exceptional health outcomes in black communities.
Categories
Information
Our Brands

Are you a healthcare professional? Register with us today!

Copyright © 2026, BlackDoctor, Inc. All rights reserved.
BlackDoctor Pro is an online destination created specifically for Black doctors and other culturally-sensitive healthcare professionals. Our platform delivers trusted, relevant, and timely medical content, including in-depth articles, the latest treatment updates, healthcare policy, and emerging clinical studies.
AI-Powered Search. Human-Created Content.